• 1
    Akdis, C. A., Kussebi, F., Pulendran, B., Akdis, M., Lauener, R. P., Schmidt-Weber, C. B., Klunker, R. P. et al., Inhibition of T helper 2-type responses, IgE production and eosinophilia by synthetic lipopeptides. Eur. J. Immunol. 2003. 33: 27172726.
  • 2
    Hessel, E. M., Chu, M., Lizcano, J. O., Chang, B., Herman, N., Kell, S. A., Wills-Karp, M. et al., Immunostimulatory oligonucleotides block allergic airway inflammation by inhibiting Th2 cell activation and IgE-mediated cytokine induction. J. Exp. Med. 2005. 202: 15631573.
  • 3
    Patel, M., Xu, D., Kewin, P., Choo-Kang, B., McSharry, C., Thoemson, N. C., and Liew, F. Y. TLR2 agonist ameliorates established allergic airway inflammation by promoting Th1 response and not via regulatory T cells. J. Immunol. 2005. 174: 75587563.
  • 4
    Revets, H., Pynaert, G., Grooten, J. and De Baetselier, P., Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J. Immunol. 2005. 174: 10971103.
  • 5
    Aumeunier, A., Grela, F., Ramadan, A., Pham Van, L., Bardel, E., Gomez Alcala, A., Jeannin, P. et al., Systemic Toll-like receptor stimulation suppresses experimental allergic asthma and autoimmune diabetes in NOD mice. PLoS One 2010. 5: e11484.
  • 6
    Moisan, J., Camateros, P., Thuraisingam, T., Marion, D., Koohsari, H., Martin, P.,Boghdady, M. L. et al., TLR7 ligand prevents allergen-induced airway hyperresponsiveness and eosinophilia in allergic asthma by a MYD88-dependent and MK2-independent pathway. Am. J. Physiol. Lung Cell Mol. Physiol. 2006. 290: L987L995.
  • 7
    Quarcoo, D., Weixler, S., Joachim, R. A., Stock, P., Kallinich, T., Ahrens, B., Hamelmann, E., Resiquimod, a new immune response modifier from the family of imidazoquinolinamines, inhibits allergen-induced Th2 responses, airway inflammation and airway hyper-reactivity in mice. Clin. Exp. Allergy 2004. 34: 13141320.
  • 8
    Sel, S., Wegmann, M., Bauer, S., Bauer, S., Gam, H., Alber, G.,Renz, H., Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J. Immunol. 2007. 178: 78057813.
  • 9
    Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanio, H., Hoshino, K., Horiuchi, T. et al., Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol. 2002. 3: 196200.
  • 10
    Jurk, M., Heil, F., Vollmer, J., Schetter, C., Krieg, A. M., Wagner, H., Lipford, G. and Bauer, S., Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848. Nat. Immunol. 2002. 3: 499.
  • 11
    Kawai, T. and Akira, S., The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 2010. 11: 373384.
  • 12
    Camateros, P., Tamaoka, M., Hassan, M., Marino, R., Moisan, J., Marion, D., Guiot, M. C. et al., Chronic asthma-induced airway remodeling is prevented by toll-like receptor-7/8 ligand S28463. Am. J. Respir. Crit. Care Med. 2007. 175: 12411249.
  • 13
    Xirakia, C., Koltsida, O., Stavropoulos, A., Thanassopoulou, A., Aidinis, V., Sideras, P. and Andreakos, E., Toll-like receptor 7-triggered immune response in the lung mediates acute and long-lasting suppression of experimental asthma. Am. J. Respir. Crit. Care Med. 2010. 181: 12071216.
  • 14
    Camateros, P., Kanagaratham, C., Henri, J., Sladek, R., Hudson, T. J. and Radzioch, D., Modulation of the allergic asthma transcriptome following resiquimod treatment. Physiol. Genomics 2009. 38: 303318.
  • 15
    Barrett, N. A. and Austen, K. F., Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 2009. 31: 425437.
  • 16
    Kearley, J., Barker, J. E., Robinson, D. S. and Lloyd, C. M., Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent. J. Exp. Med. 2005. 202: 15391547.
  • 17
    Akbari, O., Stock, P., DeKruyff, R. H. and Umetsu, D. T., Role of regulatory T cells in allergy and asthma. Curr. Opin. Immunol. 2003. 15: 627633.
  • 18
    Lagranderie, M., Abolhassani, M., Vanoirbeek, J. A., Lima, C., Balazuc, A. M., Vargaftig, B. B.,Marchal, G., Mycobacterium bovis bacillus Calmette-Guerin killed by extended freeze-drying targets plasmacytoid dendritic cells to regulate lung inflammation. J. Immunol. 2010. 184: 10621070.
  • 19
    Zuany-Amorim, C., Sawicka, E., Manlius, C., Le, M. A., Brunet, L. R., Kemeny, D. M. and Bowen, G., Suppression of airway eosinophilia by killed Mycobacterium vaccae-induced allergen-specific regulatory T-cells. Nat. Med. 2002. 8: 625629.
  • 20
    Lloyd, C. M. and Hawrylowicz, C. M., Regulatory T cells in asthma. Immunity 2009. 31: 438449.
  • 21
    Leech, M. D., Benson, R. A., De Vries, A., Fitch, P. M. and Howie, S. E., Resolution of Der p1-induced allergic airway inflammation is dependent on CD4+CD25+Foxp3+ regulatory cells. J. Immunol. 2007. 179: 70507088.
  • 22
    Joetham, A., Takeda, K., Taube, C., Miyahara, N., Matsubara, S., Koya, T., Rha, Y. H. et al., Naturally occurring lung CD4(+)CD25(+) T cell regulation of airway allergic responses depends on IL-10 induction of TGF-beta. J. Immunol. 2007. 178: 14331442.
  • 23
    Ostroukhova, M., Seguin-Devaux, C., Oriss, T. B., Dixon-McCarthy, B., Yang, L., Ameredes, B. T., Corcoran, T. E. and Ray, A., Tolerance induced by inhaled antigen involves CD4(+) T cells expressing membrane-bound TGF-beta and FOXP3. J. Clin. Invest. 2004. 114: 2838.
  • 24
    Hadeiba, H. and Locksley, R. M., Lung CD25 CD4 regulatory T cells suppress type 2 immune responses but not bronchial hyperreactivity. J. Immunol. 2003. 170: 55025510.
  • 25
    Jaffar, Z., Sivakuru, T. and Roberts, K., CD4+CD25+ T cells regulate airway eosinophilic inflammation by modulating the Th2 cell phenotype. J. Immunol. 2004. 172: 38423849.
  • 26
    Crellin, N. K., Garcia, R. V., Hadisfar, O., Allan, S. E., Steiner, T. S. and Levings, M. K., Human CD4+ T cells express TLR5 and its ligand flagellin enhances the suppressive capacity and expression of FOXP3 in CD4+CD25+ T regulatory cells. J. Immunol. 2005. 175: 80518059.
  • 27
    Grela, F., Aumeunier, A., Bardel, E., Pham Van, L., Bourgeois, E., Vanoirbeek, J., Leite-de-Moraes, M. et al., The TLR7 agonist R848 alleviates allergic inflammation by targeting invariant NKT cells to produce IFN-gamma. J. Immunol. 2011. 186: 284290.
  • 28
    Palomares, O., Yaman, G., Azkur, A. K., Akkoc, T., Akdis, M. and Akdis, C. A., Role of Treg in immune regulation of allergic diseases. Eur. J. Immunol. 2010. 40: 12321240.
  • 29
    Taher, Y. A., van Esch, B. C., Hofman, G. A., Henricks, P. A. and van Oosterhout, A. J., 1Alpha,25-dihydroxyvitamin D3 potentiates the beneficial effects of allergen immunotherapy in a mouse model of allergic asthma: role for IL-10 and TGF-beta. J. Immunol. 2008. 180: 52115221.
  • 30
    Oida, T., Zhang, X., Goto, M., Hachimura, S., Totsuka, M., Kaminogawa, S. and Weiner, H. L., CD4+CD25− T cells that express latency-associated peptide on the surface suppress CD4+CD45RBhigh-induced colitis by a TGF-beta-dependent mechanism. J. Immunol. 2003. 170: 25162522.
  • 31
    Vissers, J. L., van Esch, B. C., Hofman, G. A., Kapsenberg, M. L., Weller, F. R. and Van Oosterhout, A. J., Allergen immunotherapy induces a suppressive memory response mediated by IL-10 in a mouse asthma model. J. Allergy Clin. Immunol. 2004. 113: 12041210.